Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On 30 Aug 2017, Professor Lisa White, Head of Mathematical/Economic Modelling (MAEMOD) at MORU, led an engaging interactive Bangkok Scientifique session on the uses of mathematical modelling in infectious diseases at Café Tartine in Bangkok.

Lisa kicked things off by asking attendees to assume that an unknown infection was spreading at the café. Participants were given conical caps (photo right). Using a mathematical model, Lisa then told audience members to stand up as directed, starting with the original (index) case and proceeding as the infection spread across the room.

Lisa then discussed the role of mathematical modelling in outbreak prediction and her work at MORU to predict anti-malarial resistance. This drew audience questions on the current epidemiology of malaria control in the Greater Mekong Sub-region and possible future epidemics.

The Q&A was followed by a discussion of other infections, including the severe acute respiratory syndrome (SARS) outbreak in 2003. Lisa concluded with remarks on infectious disease prediction models and their use in guiding health interventions.

Held the last Wednesday of each month, Bangkok Scientifique is a public engagement with science initiative supported by Prof Phaik Yeong Cheah and the Department of Bioethics and Engagement at MORU. The Department seeks to engage with stakeholders including hard-to-reach audiences, those with limited literacy and the socially excluded to improve public understanding of science and enable the patient and public to be active collaborators in health systems and health research processes.  

Done throughout SE Asia, these public engagement activities in Thailand include the Tak Community Advisory Board, science theatre projectspublic engagement in classrooms and Pint of Science. The Department also supports Science Cafés in Laos and Cambodia and Young Persons’ Advisory Group and Village Drama against Malaria in Cambodia.

Similar stories

Researchers call for access to Ivermectin for young children

MORU Bangkok Publication Research

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication. The WorldWide Antimalarial Resistance Network’s new meta-analysis provides evidence that supports removing this barrier and improving treatment equity.

Evidence supports WHO recommendation for primaquine combined with ACTs to block Plasmodium falciparum transmission

MORU Bangkok Publication Research

Evidence from a new study, initiated by the Primaquine Roll Out Group and conducted at WWARN, supports the World Health Organization (WHO) recommendation for use of 0.25mg/kg dose of primaquine (PQ) combined with artemisinin-based combination therapies (ACT) to block Plasmodium falciparum transmission.

Indonesia’s decision to prioritise COVID-19 vaccination to citizens aged 18-59 years old questionable

MORU Bangkok

The Indonesian government policy to exclude the elderly in the first phase of the COVID-19 vaccination program could hinder the vaccine’s impact in lowering mortality rates. COVID-19 mortality rates in Indonesia, the highest in Southeast Asia, are dominated by those in the 60 years and above age bracket. In this article published in The Conversation, Kartika Saraswati and fellow DPhil students elaborate how, by prioritising vaccination for elderly, Indonesia may optimally reduce the hospital burden and COVID-19 deaths amidst a limited vaccine supply during the first vaccination phase.

Check-list recommended to improve reporting of microscopy methods and results in malaria studies

MORU Bangkok Publication Research

A study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.

Susie Dunachie awarded flagship NIHR career development award

Awards & Appointments MORU Bangkok

Susie Dunachie joins a prestigious group of leading health researchers in the latest cohort of NIHR Global Research Professors. These awards fund research leaders of the future to promote effective translation of research and to strengthen health, public health and care research leadership at the highest academic levels. Research conducted by Global Research Professors directly benefits people in LMICs. A Consultant in Infectious Diseases and Medical Microbiology, Susie works on the development of a vaccine to prevent death from melioidosis in people with type 2 diabetes mellitus in LMICs, and supports vaccine research in Thailand. Congratulations!

The COVID-19 vaccine: do we know enough to end the pandemic?

MORU Bangkok Research

Blog by Rima Shretta. Preliminary efficacy results from three vaccine candidates currently in Phase 3 trials have shown an efficacy of more than 90% against the development of symptomatic COVID-19. While these results are promising, all vaccines are in relatively early stages of testing. A comprehensive and transparent roadmap is urgently needed, to determine how limited doses of the first vaccines to be licensed will be distributed, together with which groups will initially be prioritized.